Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-06-18 Sale | 2025-06-20 9:09 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 6,620 | $54.84 | $363,041 | 549,867 (Direct) | View |
| 2025-06-18 Sale | 2025-06-20 9:08 pm | Akero Therapeutics Inc. | AKRO | Gangloff Scott A. Chief Technology Officer | 848 | $54.84 | $46,504 | 23,452 (Direct) | View |
| 2025-06-20 Sale | 2025-06-20 9:08 pm | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 875 | $54.59 | $47,766 | 31,698 (Direct) | View |
| 2025-06-18 Sale | 2025-06-20 9:07 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 1,129 | $54.84 | $61,914 | 166,234 (Direct) | View |
| 2025-06-18 Sale | 2025-06-20 9:07 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 1,634 | $54.84 | $89,609 | 57,521 (Direct) | View |
| 2025-06-18 Sale | 2025-06-20 9:07 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 1,633 | $54.84 | $89,554 | 90,598 (Direct) | View |
| 2025-06-18 Sale | 2025-06-20 9:06 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 1,453 | $54.84 | $79,683 | 256,594 (Indirect Direct) | View |
| 2025-06-16 Sale | 2025-06-20 09:22 am | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 10,000 | $54.23 | $542,306 | 92,231 (Direct) | View |
| 2025-06-16 Sale | 2025-06-20 09:22 am | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 2,000 | $54.14 | $108,272 | 96,755 (Direct) | View |
| 2025-06-10 Sale | 2025-06-12 6:34 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 37,837 | $54.05 | $2,044,940 | 556,487 (Direct) | View |
| 2025-06-10 Sale | 2025-06-12 6:33 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 2,358 | $54 | $127,323 | 167,363 (Direct) | View |
| 2025-06-10 Sale | 2025-06-12 6:33 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 2,804 | $53.99 | $151,402 | 59,155 (Direct) | View |
| 2025-06-10 Sale | 2025-06-12 6:33 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 2,803 | $54 | $151,351 | 92,231 (Direct) | View |
| 2025-06-10 Sale | 2025-06-12 6:32 pm | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 919 | $54 | $49,625 | 32,573 (Direct) | View |
| 2025-06-10 Sale | 2025-06-12 6:32 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 2,493 | $53.99 | $134,605 | 258,047 (Indirect Direct) | View |
| 2025-06-05 Sale | 2025-06-09 5:30 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 37,500 | $54.52 | $2,044,634 | 202,543 (Direct) | View |
| 2025-06-02 Sale | 2025-06-04 5:36 pm | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 4,000 | $50.31 | $201,258 | 99,674 (Direct) | View |
| 2025-05-22 Sale | 2025-05-23 5:30 pm | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 4,000 | $50 | $200,000 | 118,396 (Direct) | View |
| 2025-05-15 Sale | 2025-05-19 7:06 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 10,000 | $39.3 | $392,978 | 105,034 (Direct) | View |
| 2025-05-12 Sale | 2025-05-13 9:11 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 30,000 | $41.48 | $1,244,455 | 594,324 (Direct) | View |
| 2025-05-07 Sale | 2025-05-09 7:18 pm | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 8,000 | $42.49 | $339,950 | 103,674 (Direct) | View |
| 2025-05-06 Sale | 2025-05-08 7:34 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $43.43 | $542,864 | 182,610 (Direct) | View |
| 2025-04-24 Sale | 2025-04-28 6:22 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 6,250 | $41.03 | $256,438 | 221,262 (Direct) | View |
| 2025-04-15 Sale | 2025-04-16 6:00 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 9,073 | $37.91 | $343,962 | 115,034 (Direct) | View |
| 2025-04-10 Sale | 2025-04-11 6:00 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 30,000 | $35.23 | $1,056,780 | 624,324 (Direct) | View |
| 2025-04-07 Sale | 2025-04-10 6:00 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 6,250 | $35.88 | $224,262 | 198,439 (Direct) | View |
| 2025-03-25 Purchase | 2025-03-27 7:42 pm | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 200,000 | $43.94 | $8,787,921 | 1,202,168 (Indirect Direct) | View |
| 2025-03-17 Sale | 2025-03-18 5:30 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 10,000 | $44.76 | $447,605 | 95,034 (Direct) | View |
| 2025-03-12 Sale | 2025-03-14 9:18 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 1,738 | $44.88 | $78,001 | 654,324 (Direct) | View |
| 2025-03-12 Sale | 2025-03-14 8:33 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 607 | $44.88 | $27,242 | 260,540 (Indirect Direct) | View |
| 2025-03-12 Sale | 2025-03-14 8:30 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 614 | $44.88 | $27,556 | 95,034 (Direct) | View |
| 2025-03-12 Sale | 2025-03-14 8:24 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 676 | $44.88 | $30,339 | 61,959 (Direct) | View |
| 2025-03-12 Sale | 2025-03-14 8:18 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 516 | $44.88 | $23,158 | 169,721 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-16 Exercise | 2025-06-20 09:22 am | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 10,000 | $0 | 92,231 (Direct) | View |
| 2025-06-16 Exercise | 2025-06-20 09:22 am | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 10,000 | $21.1 | 92,231 (Direct) | View |
| 2025-06-16 Exercise | 2025-06-20 09:22 am | N/A 2033-12-07 | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 2,000 | $0 | 96,755 (Direct) | View |
| 2025-06-16 Exercise | 2025-06-20 09:22 am | N/A N/A | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 2,000 | $19.87 | 96,755 (Direct) | View |
| 2025-06-05 Exercise | 2025-06-09 5:30 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 37,500 | $0 | 202,543 (Direct) | View |
| 2025-06-06 Exercise | 2025-06-09 5:30 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 24,611 | $21.09 | 202,543 (Direct) | View |
| 2025-06-05 Exercise | 2025-06-09 5:30 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,889 | $21.1 | 202,543 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-05 4:07 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Henderson Jane Director | 9,398 | $0 | 9,398 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-05 4:06 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director | 9,398 | $0 | 293,762 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-05 4:06 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director | 9,398 | $0 | 9,398 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-05 4:05 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Xu Yuan Director | 9,398 | $0 | 9,398 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-05 4:05 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director | 9,398 | $0 | 9,398 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-05 4:05 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Judy Chou Director | 9,398 | $0 | 9,398 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-05 4:05 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 9,398 | $0 | 1,211,566 (Direct) | View |
| 2025-06-02 Exercise | 2025-06-04 5:36 pm | N/A 2033-12-07 | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 4,000 | $0 | 99,674 (Direct) | View |
| 2025-06-02 Exercise | 2025-06-04 5:36 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 4,000 | $19.87 | 99,674 (Direct) | View |
| 2025-05-22 Exercise | 2025-05-23 5:30 pm | N/A 2033-01-09 | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 4,000 | $0 | 118,396 (Direct) | View |
| 2025-05-22 Exercise | 2025-05-23 5:30 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 4,000 | $44.37 | 118,396 (Direct) | View |
| 2025-05-15 Exercise | 2025-05-19 7:06 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 10,000 | $0 | 105,034 (Direct) | View |
| 2025-05-15 Exercise | 2025-05-19 7:06 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 10,000 | $21.1 | 105,034 (Direct) | View |
| 2025-05-07 Exercise | 2025-05-09 7:18 pm | N/A 2033-12-07 | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 8,000 | $0 | 103,674 (Direct) | View |
| 2025-05-07 Exercise | 2025-05-09 7:18 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 8,000 | $19.87 | 103,674 (Direct) | View |
| 2025-05-06 Exercise | 2025-05-08 7:34 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $0 | 182,610 (Direct) | View |
| 2025-05-06 Exercise | 2025-05-08 7:34 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $21.1 | 182,610 (Direct) | View |
| 2025-04-24 Exercise | 2025-04-28 6:22 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 6,250 | $0 | 221,262 (Direct) | View |
| 2025-04-24 Exercise | 2025-04-28 6:22 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 6,250 | $21.1 | 221,262 (Direct) | View |
| 2025-04-15 Exercise | 2025-04-16 6:00 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 9,073 | $0 | 115,034 (Direct) | View |
| 2025-04-15 Exercise | 2025-04-16 6:00 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 9,073 | $21.1 | 115,034 (Direct) | View |
| 2025-04-07 Exercise | 2025-04-10 6:00 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 6,250 | $0 | 198,439 (Direct) | View |
| 2025-04-07 Exercise | 2025-04-10 6:00 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 6,250 | $21.1 | 198,439 (Direct) | View |
| 2025-03-17 Exercise | 2025-03-18 5:30 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 10,000 | $0 | 95,034 (Direct) | View |
| 2025-03-17 Exercise | 2025-03-18 5:30 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 10,000 | $21.1 | 95,034 (Direct) | View |